ATLANTA, Jan. 29, 2007 (PRIME NEWSWIRE) -- TGC Ventures International (Pink Sheets:TGVI) announced the Company is in the process of adding a full line of all-natural products to their recently launched Asian marketing campaign. TGC Ventures Int., motivated by the worldwide growing interest in natural and homeopathic health products is considering increasing the line of products to be marketed from their Hong Kong based head office.
These additional products will be chosen based on consumer recognition and product demand. Currently the Company is marketing an all-natural psoriasis cream and a Anti-Aging Hyaluronic Acid.
Several products such as an arthritic joint relief remedy, digestive enzymes, anti-oxidant and a high potency immune building supplement with a unique propriety blend are being considered. The products will be produced for maximum effectiveness and be competitively priced.
About TGC Ventures International Inc.:
TGC Ventures International Inc. is a medically related holding company that is targeting the burgeoning multi-trillion dollar Health Care Services and Medical Devices & Supplies Industry.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.